Quentis Therapeutics, Inc

Biotechnology ResearchNew York, United States11-50 Employees

The endoplasmic reticulum is a structure within cells that is responsible for multiple functions, including serving as a sensor of cellular stress. Persistent ER stress has a significant impact in a number of diseases including cancer and neurodegenerative disease, as well as autoimmune conditions. 

Quentis Therapeutics is translating novel biology into new therapeutic approaches to address ER stress in multiple diseases, beginning with our first program in cancer. The company’s first-in-class IRE1α inhibitor is designed to target ER stress pathways and awaken the immune system’s ability to fight cancer. Founded by a team with deep drug discovery and development experience, we are building a leading New York City-based biotechnology company driven by a commitment to scientific excellence and a passion to help patients.

Sign up for free to view info

Email Format Employee directory